Search results
V. A. Shiva Ayyadurai (born Vellayappa Ayyadurai Shiva on December 2, 1963) is an Indian-American engineer, politician, entrepreneur, and anti-vaccine activist. He has become known for promoting conspiracy theories, pseudoscience, and unfounded medical claims.
Dr.SHIVA Ayyadurai, the Inventor of Email, Scientist, Innovator, Educator, holds four degrees from M.I.T., is a Fulbright Scholar, Lemelson-MIT Awards Finalist and Westinghouse Science Talent ...
Beyond the invention of email in 1978, Dr. V.A. Shiva Ayyadurai, who holds four degrees from MIT, is a Fullbright Scholar, MIT-Lemelson Awards Finalist and Westinghouse Science Talent Search Honors Award recipient, has continued his work as both an inventor and systems scientist across a broad range of fields from media to medicine, art and ...
Dr. Shiva Ayyadurai, MIT PhD, the Inventor of Email, world-renowned scientist and engineer, holds 4 degrees from MIT, is a Fulbright Scholar, started 7 successful hi-tech companies, and is the founder of the international movement for Truth Freedom Health(R).
Nov 3, 2020 · Shiva Ayyadurai (independent) is running for election to the U.S. Senate to represent Massachusetts. He declared candidacy for the general election scheduled on November 5, 2024 . Ayyadurai is also running for election for President of the United States.
Feb 22, 2012 · In the summer of 1979, a 14-year-old high school student named Shiva Ayyadurai was given an unusual project.
Dr. V.A. Shiva Ayyadurai, the inventor of email and polymath, holds four degrees from MIT, is a world-renowned systems scientist, inventor and entrepreneur.
May 17, 2019 · Shiva Ayyadurai claimed for years that he invented email. Techdirt refuted his claims. Ayyadurai sued, and now the lawsuit has ended. The stories remain up.
Dr. Shiva Ayyadurai, MIT PhD, the Inventor of Email, Candidate for U.S. President, and… · Experience: Shiva4President.com · Education: Massachusetts Institute of Technology · Location ...
- Shiva4President.com
Shiva is the Chairman & CEO of CytoSolve Inc., which provides a revolutionary platform for modeling complex diseases and developing multi-combination therapeutics.
